| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |